BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35017168)

  • 1. Using Machine Learning to Identify Metabolomic Signatures of Pediatric Chronic Kidney Disease Etiology.
    Lee AM; Hu J; Xu Y; Abraham AG; Xiao R; Coresh J; Rebholz C; Chen J; Rhee EP; Feldman HI; Ramachandran VS; Kimmel PL; Warady BA; Furth SL; Denburg MR;
    J Am Soc Nephrol; 2022 Feb; 33(2):375-386. PubMed ID: 35017168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untargeted urine metabolomics and machine learning provide potential metabolic signatures in children with autism spectrum disorder.
    Liu X; Sun X; Guo C; Huang ZF; Chen YR; Feng FM; Wu LJ; Chen WX
    Front Psychiatry; 2024; 15():1261617. PubMed ID: 38445087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease risk among children with focal segmental glomerulosclerosis: a report from the chronic kidney disease in children study.
    Sethna CB; Ng DK; Jiang S; Saland J; Warady BA; Furth S; Meyers KE
    Pediatr Nephrol; 2019 Aug; 34(8):1403-1412. PubMed ID: 30903375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis.
    Bai J; Pu X; Zhang Y; Dai E
    Ren Fail; 2022 Dec; 44(1):966-986. PubMed ID: 35713363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolites Associated With Uremic Symptoms in Patients With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Wulczyn KE; Shafi T; Anderson A; Rincon-Choles H; Clish CB; Denburg M; Feldman HI; He J; Hsu CY; Kelly T; Kimmel PL; Mehta R; Nelson RG; Ramachandran V; Ricardo A; Shah VO; Srivastava A; Xie D; Rhee EP; Kalim S;
    Am J Kidney Dis; 2024 Jan; ():. PubMed ID: 38266973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort.
    Wang H; Wang Y; Li X; Deng X; Kong Y; Wang W; Zhou Y
    Cardiovasc Diabetol; 2022 Dec; 21(1):288. PubMed ID: 36564831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rule-Mining for the Early Prediction of Chronic Kidney Disease Based on Metabolomics and Multi-Source Data.
    Luck M; Bertho G; Bateson M; Karras A; Yartseva A; Thervet E; Damon C; Pallet N
    PLoS One; 2016; 11(11):e0166905. PubMed ID: 27861591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating bacterial peptides and linked metabolomic signatures are indicative of early mortality in pediatric cirrhosis.
    Mathew B; Tripathi G; Gautam V; Bindal V; Sharma N; Yadav M; Pandey S; Sharma N; Gupta AC; Bhat SH; Saini AK; Sood V; Lal BB; Alam S; Khanna R; Maras JS
    Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38836842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity.
    Wang H; Ainiwaer A; Song Y; Qin L; Peng A; Bao H; Qin H
    Microbiome; 2023 Jan; 11(1):3. PubMed ID: 36624472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?
    Anderson AB; Grazal CF; Balazs GC; Potter BK; Dickens JF; Forsberg JA
    Clin Orthop Relat Res; 2020 Jul; 478(7):0-1618. PubMed ID: 32282466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease.
    Wu IW; Gao SS; Chou HC; Yang HY; Chang LC; Kuo YL; Dinh MCV; Chung WH; Yang CW; Lai HC; Hsieh WP; Su SC
    Theranostics; 2020; 10(12):5398-5411. PubMed ID: 32373220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasopharyngeal metabolomics and machine learning approach for the diagnosis of influenza.
    Hogan CA; Rajpurkar P; Sowrirajan H; Phillips NA; Le AT; Wu M; Garamani N; Sahoo MK; Wood ML; Huang C; Ng AY; Mak J; Cowan TM; Pinsky BA
    EBioMedicine; 2021 Sep; 71():103546. PubMed ID: 34419924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The link between phenotype and fatty acid metabolism in advanced chronic kidney disease.
    Chen DQ; Chen H; Chen L; Vaziri ND; Wang M; Li XR; Zhao YY
    Nephrol Dial Transplant; 2017 Jul; 32(7):1154-1166. PubMed ID: 28339984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Untargeted metabolomics for plasma biomarker discovery for early chronic kidney disease diagnosis in pediatric patients using LC-QTOF-MS.
    Benito S; Sánchez-Ortega A; Unceta N; Andrade F; Aldámiz-Echevarria L; Goicolea MA; Barrio RJ
    Analyst; 2018 Sep; 143(18):4448-4458. PubMed ID: 30151522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Metabolomics Identifies Dysregulated Pathways and Potential Metabolic Biomarkers for Hyperuricemia and Gout.
    Shen X; Wang C; Liang N; Liu Z; Li X; Zhu ZJ; Merriman TR; Dalbeth N; Terkeltaub R; Li C; Yin H
    Arthritis Rheumatol; 2021 Sep; 73(9):1738-1748. PubMed ID: 33760368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
    Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality and Allograft Loss Trends Among US Pediatric Kidney Transplant Recipients With and Without Focal Segmental Glomerulosclerosis.
    Wang CS; Gander J; Patzer RE; Greenbaum LA
    Am J Kidney Dis; 2018 Mar; 71(3):392-398. PubMed ID: 29277509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Logistic regression was as good as machine learning for predicting major chronic diseases.
    Nusinovici S; Tham YC; Chak Yan MY; Wei Ting DS; Li J; Sabanayagam C; Wong TY; Cheng CY
    J Clin Epidemiol; 2020 Jun; 122():56-69. PubMed ID: 32169597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolome-based signature of disease pathology in MS.
    Andersen SL; Briggs FBS; Winnike JH; Natanzon Y; Maichle S; Knagge KJ; Newby LK; Gregory SG
    Mult Scler Relat Disord; 2019 Jun; 31():12-21. PubMed ID: 30877925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of Two Metabolomic Platforms in CKD.
    Rhee EP; Waikar SS; Rebholz CM; Zheng Z; Perichon R; Clish CB; Evans AM; Avila J; Denburg MR; Anderson AH; Vasan RS; Feldman HI; Kimmel PL; Coresh J;
    Clin J Am Soc Nephrol; 2019 Jan; 14(1):40-48. PubMed ID: 30573658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.